NeuroPace Future Growth
Future criteria checks 2/6
NeuroPace is forecast to grow earnings and revenue by 26.9% and 21.9% per annum respectively. EPS is expected to grow by 31.4% per annum. Return on equity is forecast to be -339.8% in 3 years.
Key information
26.9%
Earnings growth rate
31.4%
EPS growth rate
| Medical Equipment earnings growth | 16.8% |
| Revenue growth rate | 21.9% |
| Future return on equity | -339.8% |
| Analyst coverage | Good |
| Last updated | 19 Dec 2024 |
Recent future growth updates
Recent updates
After Leaping 90% NeuroPace, Inc. (NASDAQ:NPCE) Shares Are Not Flying Under The Radar
Dec 04
Here's What Analysts Are Forecasting For NeuroPace, Inc. (NASDAQ:NPCE) After Its Third-Quarter Results
Nov 14Does NeuroPace (NASDAQ:NPCE) Have A Healthy Balance Sheet?
Nov 07NeuroPace, Inc. (NASDAQ:NPCE) Screens Well But There Might Be A Catch
Aug 03Is NeuroPace (NASDAQ:NPCE) Weighed On By Its Debt Load?
Apr 12NeuroPace: Picking Up The Pace
Feb 25Why Investors Shouldn't Be Surprised By NeuroPace, Inc.'s (NASDAQ:NPCE) 58% Share Price Surge
Jan 22NeuroPace, Inc. (NASDAQ:NPCE) Stock Rockets 39% But Many Are Still Ignoring The Company
Apr 17NeuroPace announces U.S. distribution agreement with DIXI Medical
Aug 11NeuroPace EPS misses by $32.45, beats on revenue; issues guidance
Jun 03Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 110 | -18 | -8 | -8 | 5 |
| 12/31/2025 | 91 | -27 | -16 | -18 | 6 |
| 12/31/2024 | 79 | -29 | -19 | -20 | 6 |
| 9/30/2024 | 76 | -28 | -17 | -16 | N/A |
| 6/30/2024 | 72 | -30 | -17 | -17 | N/A |
| 3/31/2024 | 69 | -32 | -18 | -18 | N/A |
| 12/31/2023 | 65 | -33 | -20 | -20 | N/A |
| 9/30/2023 | 60 | -38 | -24 | -24 | N/A |
| 6/30/2023 | 55 | -42 | -29 | -29 | N/A |
| 3/31/2023 | 49 | -46 | -36 | -35 | N/A |
| 12/31/2022 | 46 | -47 | -37 | -37 | N/A |
| 9/30/2022 | 44 | -47 | -38 | -37 | N/A |
| 6/30/2022 | 43 | -43 | -35 | -35 | N/A |
| 3/31/2022 | 45 | -39 | -31 | -30 | N/A |
| 12/31/2021 | 45 | -36 | -25 | -25 | N/A |
| 9/30/2021 | 45 | -30 | -23 | -23 | N/A |
| 6/30/2021 | 47 | -26 | -24 | -24 | N/A |
| 3/31/2021 | 42 | -26 | -21 | -21 | N/A |
| 12/31/2020 | 41 | -24 | -22 | -22 | N/A |
| 12/31/2019 | 37 | -30 | -25 | -25 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NPCE is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NPCE is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NPCE is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NPCE's revenue (21.9% per year) is forecast to grow faster than the US market (9.2% per year).
High Growth Revenue: NPCE's revenue (21.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NPCE is forecast to be unprofitable in 3 years.
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 02:35 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NeuroPace, Inc. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Polark | Baird |
| Ross Osborn | Cantor Fitzgerald & Co. |
| Robert Marcus | J.P. Morgan |